Jacksonville, FL, United States of America

Sharie Haugabook

This inventor holds 2 USPTO granted patents. Top assignee: Mayo Foundation for Medical Education and Research. Active years: 2003-2007.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Sharie Haugabook. Retrieved from https://idiyas.com/inventor/sharie-haugabook

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 50.0

Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:


Years Active: 2003-2007

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Sharie Haugabook: Innovator in Medical Research

Introduction

Sharie Haugabook is a prominent inventor based in Jacksonville, FL (US). She has made significant contributions to the field of medical research, particularly in the development of methods to reduce beta-amyloid polypeptides, which are associated with various neurological conditions.

Latest Patents

Haugabook holds 2 patents that focus on innovative methods for reducing the levels of beta-amyloid (Aβ) polypeptides. Her first patent details methods of reducing Aβ polypeptides using an extract, along with the production of an active fraction from this extract. Additionally, it includes a composition containing the active fraction and an article of manufacture featuring such a composition. Her second patent similarly addresses methods of reducing Aβ polypeptides, specifically utilizing a Cimicifuga extract, and also covers the production of an active fraction from this extract.

Career Highlights

Sharie Haugabook is affiliated with the Mayo Foundation for Medical Education and Research, where she continues to advance her research and innovations. Her work is crucial in the ongoing fight against diseases linked to beta-amyloid accumulation.

Collaborations

Haugabook collaborates with esteemed colleagues, including Christopher B. Eckman and Debra Yager, who contribute to her research endeavors and help enhance the impact of her inventions.

Conclusion

Sharie Haugabook's innovative work in reducing beta-amyloid polypeptides showcases her dedication to medical research and her role as a leading inventor in the field. Her contributions are vital for advancing treatments for neurological conditions.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…